MUMSS
BSX icon

Mitsubishi UFJ Morgan Stanley Securities’s Boston Scientific BSX Stock Holding History

Mitsubishi UFJ Morgan Stanley Securities’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,368
Closed -$226K – 159
2025
Q4 		$226K Buy
+2,368
New +$232K 0.36% 86
2021
Q3 		– Sell
-1,330
Closed -$57K – 106
2021
Q2 		$57K Buy
+1,330
New +$56K 0.42% 56

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Mitsubishi UFJ Morgan Stanley Securities's BSX Position: Q1 2026 in Review

Mitsubishi UFJ Morgan Stanley Securities sold out of Boston Scientific (BSX) in Q1 2026, closing a stake of 2,368 shares — an estimated $226K sold.

Mitsubishi UFJ Morgan Stanley Securities first reported a position in BSX in Q2 2021 and held it in 2 quarters. The position peaked at $226K in Q4 2025. 1,683 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Mitsubishi UFJ Morgan Stanley Securities reported no remaining Boston Scientific position as of Q1 2026 after selling out during the quarter.
  • Mitsubishi UFJ Morgan Stanley Securities sold 2,368 Boston Scientific shares in Q1 2026, an estimated $226K.
  • Mitsubishi UFJ Morgan Stanley Securities first reported a position in Boston Scientific in Q2 2021 and held it in 2 quarters.
  • Mitsubishi UFJ Morgan Stanley Securities's Boston Scientific position peaked at $226K in Q4 2025.
  • 1,683 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Mitsubishi UFJ Morgan Stanley Securities's 13F filing for Q1 2026, filed 30 Apr 2026.